Intellia Therapeutics (NTLA)
NASDAQ:NTLA

Intellia Therapeutics (NTLA) Similar Stocks

2,757 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Intellia Therapeutics
$2.44B
-4.93
-36.88%
15 Buy
4 Hold
0 Sell
Strong Buy
$59.73
Editas Medicine
$428.46M
-2.67
-35.22%
3 Buy
7 Hold
0 Sell
Moderate Buy
$11.50
Crispr Therapeutics AG
$4.78B
-21.01
3.01%
9 Buy
6 Hold
2 Sell
Moderate Buy
$75.13
Sangamo Biosciences
$81.99M
-0.22
-69.70%
3 Buy
1 Hold
0 Sell
Strong Buy
$3.33

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
NTLA
Intellia Therapeutics
26.46
-14.51
-35.42%
EDIT
Editas Medicine
5.61
-2.89
-34.00%
CRSP
Crispr Therapeutics AG
57.19
1.75
3.16%
SGMO
Sangamo Biosciences
0.40
-0.81
-66.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis